» Articles » PMID: 36097312

HIV Pre-exposure Prophylaxis at Two Urban Obstetrics/Gynecology Clinics in Buffalo: Awareness and Attitudes Among Non-Hispanic Black Vs. Latinx Patients

Overview
Date 2022 Sep 13
PMID 36097312
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Non-Hispanic Black and Latinx women are disproportionately affected by HIV when compared to the general population. This study evaluated awareness of and attitude towards PrEP, self-perceived HIV infection risk, and factors constituting high-risk behavior for HIV infection at two general OB/GYN clinics in Erie County, which exhibited a 31.6% increase in HIV cases from 2019 to 2020.

Methods: One thousand twenty-five self-administered surveys were analyzed.

Results: Of participants, 69.3% were non-Hispanic Black, 13.4% were Latinx, and 22.4% were White. There was no significant difference in awareness of or attitude toward PrEP between non-Hispanic Black and Latinx participants (p = 0.197, p = 0.467). Latinx participants exhibited the lowest awareness of PrEP compared with non-Hispanic Black and White participants (p = 0.002).

Conclusions: In our high-risk group, most participants had low self-perceived risk of HIV infection and low awareness of PrEP, and most were unwilling or unsure as to whether they would take PrEP. This calls attention to a need for improved counseling regarding PrEP and what constitutes risk of HIV infection at our general OB/GYN clinics, with a potential focus on Latinx individuals.

References
1.
Raifman J, Schwartz S, Sosnowy C, Montgomery M, Almonte A, Bazzi A . Brief Report: Pre-exposure Prophylaxis Awareness and Use Among Cisgender Women at a Sexually Transmitted Disease Clinic. J Acquir Immune Defic Syndr. 2018; 80(1):36-39. PMC: 6293982. DOI: 10.1097/QAI.0000000000001879. View

2.
Baeten J, Donnell D, Ndase P, Mugo N, Campbell J, Wangisi J . Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012; 367(5):399-410. PMC: 3770474. DOI: 10.1056/NEJMoa1108524. View

3.
Calabrese S, Tekeste M, Mayer K, Magnus M, Krakower D, Kershaw T . Considering Stigma in the Provision of HIV Pre-Exposure Prophylaxis: Reflections from Current Prescribers. AIDS Patient Care STDS. 2019; 33(2):79-88. PMC: 6386080. DOI: 10.1089/apc.2018.0166. View

4.
Pasipanodya E, Stockman J, Phuntsog T, Morris S, Psaros C, Landovitz R . "PrEP"ing for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women. BMC Womens Health. 2021; 21(1):220. PMC: 8146684. DOI: 10.1186/s12905-021-01348-8. View

5.
Goparaju L, Praschan N, Warren-Jeanpiere L, Experton L, Young M, Kassaye S . Stigma, Partners, Providers and Costs: Potential Barriers to PrEP Uptake among US Women. J AIDS Clin Res. 2017; 8(9). PMC: 5708581. DOI: 10.4172/2155-6113.1000730. View